article thumbnail

Adeptrix Closes Series A Financing to Commercialize BAMS™ Bioanalytical Reagents for Life Science Research

BioTech 365

Adeptrix Closes Series A Financing to Commercialize BAMS™ Bioanalytical Reagents for Life Science Research Adeptrix Closes Series A Financing to Commercialize BAMS™ Bioanalytical Reagents for Life Science Research BEVERLY, Mass.–(BUSINESS

Reagent 40
article thumbnail

PerkinElmer Life Sciences division becomes Revvity

Drug Discovery World

PerkinElmer’s Life Sciences division has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company. The post PerkinElmer Life Sciences division becomes Revvity appeared first on Drug Discovery World (DDW).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PerkinElmer’s Life Science and Diagnostics business becomes Revvity

Drug Discovery World

PerkinElmer’s Life Science and Diagnostics business has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company. The post PerkinElmer’s Life Science and Diagnostics business becomes Revvity appeared first on Drug Discovery World (DDW).

article thumbnail

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement

BioTech 365

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents DUBLIN & SEOUL–(BUSINESS WIRE)–ERS Genomics Limited, which … Continue reading →

article thumbnail

Up to 8 recipients to be awarded grants for genomic research

Drug Discovery World

Beckman Coulter Life Sciences has released a call for registrations for its SPRI Grants for Genomic Research, which the company describes as part of its commitment to the next generation of researchers and scientists. . We’re proud to be a part of the journey of researchers and are eager to review submissions.” .

Genome 52
article thumbnail

Video: Solving your issues with fragmented supply chains, failed projects and disjointed services

Drug Discovery World

Securing life sciences supply chains – where chemistry meets biology and products meet services. Biosynth is at the edge of innovation.

Reagent 52
article thumbnail

Danaher to acquire Abcam

Drug Discovery World

Founded in 1998 and headquartered in Cambridge, UK, Abcam provides antibodies, reagents, biomarkers and assays for drug discovery, life sciences research, and diagnostics. Abcam is expected to operate as a standalone operating company and brand within Danaher’s Life Sciences segment.